GSK Seeks EMA Approval to Expand RSV Vaccine Arexvy Use to Adults Aged 18+
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) has announced that the European Medicines Agency (EMA)...
GSK
GSK Licenses Shigella Vaccine to Bharat Biotech for Low- and Middle-Income Countries
UK-based GSK plc (NYSE: GSK) announced a licensing agreement with Bharat Biotech International Limited, an...
GSK’s Linerixibat NDA Accepted by FDA for Cholestatic Pruritus in PBC Patients
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced that the New Drug Application (NDA) for...
GSK Halts PIVOT-PO Trial Early as Tebipenem HBr Meets Efficacy Targets for cUTI
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced the early termination of the pivotal Phase...
GSK’s Blenrep Recommended for EU Approval in Multiple Myeloma
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced that its Blenrep (belantamab mafodotin) has been...
GSK’s Nucala Receives FDA Approval for COPD Treatment
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced that it has received marketing approval from...
GSK’s Blenrep Receives Marketing Approval in Japan for Multiple Myeloma
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced that it has received marketing approval from...
GSK Signs Deal to Acquire Boston Pharmaceuticals’ Efimosfermin Alpha
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) has entered into an agreement to acquire BP...
Grand Pharma Secures NMPA Approval for Fluticasone Nasal Spray
China-based Grand Pharmaceutical Group Co., Ltd. (HKG: 0512) has obtained marketing authorization from China’s National...
GSK’s Arexvy RSV Vaccine Receives Favorable ACIP Vote for Adults Aged 50-59
UK-based pharmaceutical major GlaxoSmithKline (GSK, NYSE: GSK) has announced a favorable vote from the US...
GSK’s Blenrep Approved by UK MHRA for Multiple Myeloma Treatment
UK-based pharmaceutical giant UK-based pharmaceutical company GlaxoSmithKline (GSK, NYSE: GSK) has announced the receipt of...
Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion
Tianjin Pharmaceutical Da Ren Tang Group Co., Ltd. (SHA: 600329), a traditional Chinese medicine (TCM)...
ABL Bio and GSK Partner on Neurodegenerative Disease Therapies with Grabody-B Platform
South Korea-based clinical-stage biotech ABL Bio Inc. (KOSDAQ: 298380) has entered into a licensing agreement...
GSK’s Blujepa Approved by FDA for Uncomplicated Urinary Tract Infections
UK-based pharmaceutical company GlaxoSmithKline (GSK; NYSE: GSK) announced that it has received marketing approval from...
GSK’s Nucala Accepted for EMA Review for COPD Treatment
UK-based GSK plc’s (LON: GSK, NYSE: GSK) application for expanding the use of its anti-interleukin-15...
Clover Biopharmaceuticals Receives FDA Approval for SCB-1019 RSV Vaccine Trial
China-based Clover Biopharmaceuticals Ltd., (HKG: 2197) has announced receiving clinical approval from the US Food...
Hansoh Pharmaceutical Reports 21% Revenue Growth, Boosted by Innovative Drugs
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) released its 2024 financial report last week,...
GSK’s Nucala Receives NMPA Review for COPD Treatment
GSK plc (LON: GSK, NYSE: GSK) announced that the National Medical Products Administration (NMPA) has...
GSK and Abbott Announce Leadership Changes in Key Roles
Recent days have seen significant leadership changes at two pharmaceutical giants: UK-based GSK plc (LON:...
GSK’s Penmenvy Meningococcal Vaccine Approved by FDA for Ages 10-25
UK-based multinational GSK plc (LON: GSK) announced that it has received marketing approval from the...